Siemens Healthineers AG (ETR:SHL)

Revenue by Geography

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015
EMEA Revenue	7.66B	7.56B	7.44B
EMEA Revenue Growth	1.35%	1.55%	6.47%
Americas Revenue	10.21B	10.28B	9.43B
Americas Revenue Growth	-0.73%	9.07%	6.38%
Asia Pacific Japan Revenue (Post-FY2022 Reporting)	2.88B	3.06B	2.94B
Asia Pacific Japan Revenue (Post-FY2022 Reporting) Growth	-5.83%	3.77%	-2.16%
China Revenue	2.32B	2.48B	2.55B
China Revenue Growth	-6.41%	-2.67%	-9.61%
Revenue (Other)	2.00M	-	1.00M
Revenue (Total)	23.07B	23.38B	22.36B
Revenue (Total) Growth	-1.32%	4.52%	3.15%

Revenue

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015
Imaging Revenue	12.66B	13.18B	12.27B
Imaging Revenue Growth	-3.99%	7.46%	3.59%
Diagnostics Revenue	4.13B	4.35B	4.42B
Diagnostics Revenue Growth	-5.08%	-1.58%	-2.45%
Varian Revenue	-	4.08B	3.87B
Varian Revenue Growth	-	5.56%	8.57%
Advanced Therapies Revenue	-	2.13B	2.08B
Advanced Therapies Revenue Growth	-	2.55%	2.77%
Eliminations from Revenue	-164.00M	-363.00M	-262.00M
Revenue (Other)	6.45B	-	-
Revenue (Total)	23.07B	23.38B	22.36B
Revenue (Total) Growth	-1.32%	4.52%	3.15%

EBT

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015
Imaging Income Before Taxes	2.70B	2.73B	2.58B
Imaging Income Before Taxes Growth	-1.17%	5.73%	0.31%
Diagnostics Income Before Taxes	208.00M	333.00M	235.00M
Diagnostics Income Before Taxes Growth	-37.54%	41.70%	571.43%
Varian Income Before Taxes	-	703.00M	639.00M
Varian Income Before Taxes Growth	-	10.02%	18.77%
Advanced Therapies Income Before Taxes	-	327.00M	338.00M
Advanced Therapies Income Before Taxes Growth	-	-3.25%	8.68%
Eliminations from Income Before Taxes	-1.18B	-1.24B	-1.27B

Key Performance Indicators

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015
Equipment Book-to-Bill Ratio	1.14	1.11
Equipment Book-to-Bill Ratio Growth	2.70%	-3.48%

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error